{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:03:09Z","timestamp":1794870189565,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1136\/ijgc-2019-001131","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T08:35:37Z","timestamp":1593160537000},"page":"1878-1886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Mick J E","family":"van den Akker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8581-4753","authenticated-orcid":false,"given":"Nanda","family":"Horeweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jogchum Jan","family":"Beltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2019-001131_bb0010","author":"Union for International Cancer Control","year":"2019","journal-title":"New global cancer data: GLOBOCAN 2018"},{"key":"10.1136\/ijgc-2019-001131_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2019-001131_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-001131_bb0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/ijgc-00009577-200605000-00026","article-title":"Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study","volume":"16","author":"Pieterse","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-001131_bb0035","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ygyno.2004.11.007","article-title":"Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group\/Southwest Oncology Group\/Radiation Therapy Oncology Group trial","volume":"96","author":"Monk","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0045","author":"Gynecologic Oncology Group","year":"2019","journal-title":"Randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I\/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy"},{"key":"10.1136\/ijgc-2019-001131_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00066-012-0123-2","article-title":"Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer","volume":"188","author":"Heinzelmann","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1136\/ijgc-2019-001131_bb0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ajco.12476","article-title":"Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer","volume":"12","author":"Lan","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0060","first-page":"4205","article-title":"Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer","volume":"29","author":"Fabrini","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2019-001131_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10397-008-0382-1","article-title":"The Swift operation: a modification of the Leiden nerve-sparing radical hysterectomy","volume":"5","author":"Trimbos","year":"2008","journal-title":"Gynecol Surg"},{"key":"10.1136\/ijgc-2019-001131_bb0070","author":"Hoskin","year":"2016","journal-title":"The GEC ESTRO Handbook of Brachytherapy. Part II: clinical practice, version 1"},{"key":"10.1136\/ijgc-2019-001131_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2019-001131_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2019-001131_bb0085","author":"Cancer Therapy Evaluation Program","year":"2003","journal-title":"Common terminology criteria for adverse events v3.0 (CTCAE)"},{"key":"10.1136\/ijgc-2019-001131_bb0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1136\/ijgc-2019-001131_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011711","article-title":"Prognostic significance of lymph node ratio in node-positive cervical cancer patients","volume":"97","author":"Joo","year":"2018","journal-title":"Medicine"},{"key":"10.1136\/ijgc-2019-001131_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/gyno.1999.5527","article-title":"The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy","volume":"75","author":"Tsai","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ijgc-2018-000057","article-title":"Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer","author":"Horeweg","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-001131_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0120","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN Working Group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0125","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/S1470-2045(12)70011-6","article-title":"Nodal-staging surgery for locally advanced cervical cancer in the era of PET","volume":"13","author":"Gouy","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2019-001131_bb0135","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2018.03.026","article-title":"Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study","volume":"127","author":"Najjari Jamal","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0140","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0145","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2009.11.019","article-title":"Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors?","volume":"79","author":"Ryu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2019-001131_bb0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2014.04.045","article-title":"Post-operative radiotherapy in patients with early stage cervical cancer","volume":"134","author":"D\u00e1vila Fajardo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2019-001131_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737140.2016.1121108","article-title":"Immunotherapy and targeted therapy for cervical cancer: an update","volume":"16","author":"Menderes","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1136\/ijgc-2019-001131_bb0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/18715206113136660372","article-title":"The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy","volume":"14","author":"van Meir","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1136\/ijgc-2019-001131_bb0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clinthera.2016.02.007","article-title":"Beyond chemotherapy: an overview and review of targeted therapy in cervical cancer","volume":"38","author":"Crafton","year":"2016","journal-title":"Clin Ther"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24012337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24012337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2019-001131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:24:56Z","timestamp":1753233896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24012337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1048891X24012337"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2019-001131","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2019-001131.supp1","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2019-001131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}